デフォルト表紙
市場調査レポート
商品コード
1422774

次世代シーケンシングの世界市場:製品別、シーケンシングタイプ別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年

Next-Generation Sequencing Market Assessment, By Product, By Sequencing Type, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 223 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
次世代シーケンシングの世界市場:製品別、シーケンシングタイプ別、技術別、用途別、エンドユーザー別、地域別、機会、予測、2017年~2031年
出版日: 2024年02月12日
発行: Market Xcel - Markets and Data
ページ情報: 英文 223 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の次世代シーケンシングの市場規模は、予測期間の2024年~2031年に17.52%のCAGRで拡大し、2023年の105億9,000万米ドルから2031年には385億2,000万米ドルに成長すると予測されています。世界の次世代シーケンシング市場の成長と拡大を後押ししているのは、さまざまな要素です。主な要因としては、コストの削減、臨床診断における用途の拡大、技術の進歩、研究活動の拡大、共同パートナーシップ、農業および動物ゲノムにおける幅広い用途、個別化医療に対する需要の高まり、政府の支援イニシアティブと資金提供、NGS技術に対する認識と受容の高まりなどが挙げられます。

これに伴い、シーケンシング費用の継続的な減少により、研究者や臨床医がさまざまな分野でNGSを利用できるようになり、利用可能性が著しく拡大した。同時に、臨床診断におけるNGSの急増は、病気の特定、治療計画、個別化医療の領域でその能力を活用し、ヘルスケアにおけるNGSの重要性を高めるという変革をもたらしています。シーケンシング技術の進歩の礎石は、一貫して精度、スピード、費用対効果を向上させ、それによってNGSの多様な産業における魅力を高め、世界の次世代シーケンス市場の成長を後押ししています。この勢いは、学術、製薬、バイオテクノロジーの研究事業の急増によってさらに促進され、ゲノミクスとその実用的な応用のより深い探求を可能にしています。

世界の次世代シーケンシング市場における相乗的な協力関係やパートナーシップは技術革新に拍車をかけ、製品の強化を推進し、NGSアプリケーションのスペクトルを広げています。さらに、農業および動物ゲノミクスにおけるNGSの統合は、作物の改良、育種プログラム、および疾病分析に関連する実践に革命をもたらし、その有用性はヒトヘルスケア以外にも広がっています。個別化医療に対する需要の高まりは、テーラーメイドの治療のために個々の遺伝的変異を解読するNGSの能力を活用する、極めて重要な推進力として浮上してきました。政府の積極的な取り組みと資金援助は、研究、進歩、そしてNGS技術の広範な採用を後押ししています。結局のところ、科学界や一般住民の間でNGSに対する認識と受容が高まっていることがその重要性を高め、世界の次世代シーケンシング市場全体で革新と進歩に不可欠な機器としての極めて重要な役割を確固たるものにしています。

当レポートでは、世界の次世代シーケンシング市場について調査し、市場の概要とともに、製品別、シーケンシングタイプ別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の次世代シーケンシング市場の見通し、2017年~2031年

  • 市場規模と予測
  • 製品別
  • シーケンシングタイプ別
  • 技術別
  • 用途別
  • エンドユーザー別
  • 地域別
  • 企業別市場シェア(%)、2023年

第5章 世界の次世代シーケンシング市場の見通し、地域別、2017年~2031年

  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸出入分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

第9章 規制の枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • BGI Group
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Macrogen, Inc.
  • Pacific Biosciences of California, Inc.
  • Genewiz, LLC
  • 10x Genomics, Inc.
  • Oxford Nanopore Technologies plc
  • F. Hoffmann-La Roche AG

第14章 戦略的提言

第15章 お問合せと免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 3. Global Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 5. Global Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 6. Global Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 7. Global Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 8. Global Next-Generation Sequencing Market Share (%), By Region, 2017-2031F
  • Figure 9. North America Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 11. North America Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 12. North America Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 13. North America Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 14. North America Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 15. North America Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 16. North America Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 17. United States Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 19. United States Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 20. United States Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 21. United States Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 22. United States Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 23. United States Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 24. Canada Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 26. Canada Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 27. Canada Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 28. Canada Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 29. Canada Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 31. Mexico Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 33. Mexico Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 34. Mexico Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 35. Mexico Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 36. Mexico Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 38. Europe Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 40. Europe Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 41. Europe Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 42. Europe Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 43. Europe Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 45. Europe Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 48. Germany Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 49. Germany Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 50. Germany Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 51. Germany Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 53. France Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 55. France Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 56. France Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 57. France Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 58. France Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 59. France Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 60. Italy Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 62. Italy Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 63. Italy Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 64. Italy Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 65. Italy Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 67. United Kingdom Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 69. United Kingdom Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 70. United Kingdom Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 71. United Kingdom Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 72. United Kingdom Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 74. Russia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 76. Russia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 77. Russia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 78. Russia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 79. Russia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 80. Russia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 81. Netherlands Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 83. Netherlands Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 84. Netherlands Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 85. Netherlands Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 86. Netherlands Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 87. Netherlands Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 88. Spain Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 90. Spain Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 91. Spain Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 92. Spain Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 93. Spain Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 94. Spain Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 95. Turkey Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 97. Turkey Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 98. Turkey Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 99. Turkey Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 100. Turkey Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 101. Turkey Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 102. Poland Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 104. Poland Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 105. Poland Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 106. Poland Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 107. Poland Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 108. Poland Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 109. South America Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 111. South America Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 112. South America Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 113. South America Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 114. South America Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 115. South America Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 116. South America Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 119. Brazil Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 120. Brazil Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 121. Brazil Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 122. Brazil Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 123. Brazil Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 124. Argentina Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 126. Argentina Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 127. Argentina Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 128. Argentina Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 129. Argentina Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 130. Argentina Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 131. Asia-Pacific Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 133. Asia-Pacific Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 134. Asia-Pacific Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 135. Asia-Pacific Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 136. Asia-Pacific Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 137. Asia- Pacific Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 138. Asia-Pacific Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 139. India Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 141. India Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 142. India Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 143. India Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 144. India Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 145. India Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 146. China Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 148. China Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 149. China Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 150. China Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 151. China Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 152. China Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 153. Japan Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 155. Japan Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 156. Japan Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 157. Japan Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 158. Japan Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 159. Japan Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 160. Australia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 162. Australia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 163. Australia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 164. Australia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 165. Australia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 166. Australia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 167. Vietnam Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 169. Vietnam Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 170. Vietnam Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 171. Vietnam Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 172. Vietnam Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 173. Vietnam Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 174. South Korea Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 176. South Korea Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 177. South Korea Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 178. South Korea Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 179. South Korea Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 180. South Korea Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 181. Indonesia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 183. Indonesia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 184. Indonesia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 185. Indonesia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 186. Indonesia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 187. Indonesia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 188. Philippines Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 190. Philippines Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 191. Philippines Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 192. Philippines Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 193. Philippines Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 194. Philippines Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 195. Middle East & Africa Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 197. Middle East & Africa Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 198. Middle East & Africa Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 199. Middle East & Africa Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 200. Middle East & Africa Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 201. Middle East & Africa Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 202. Middle East & Africa Next-Generation Sequencing Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 205. Saudi Arabia Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 206. Saudi Arabia Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 207. Saudi Arabia Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 208. Saudi Arabia Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 209. Saudi Arabia Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 210. UAE Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 212. UAE Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 213. UAE Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 214. UAE Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 215. UAE Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 216. UAE Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 217. South Africa Next-Generation Sequencing Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa Next-Generation Sequencing Market, By Volume, In Millions, 2017-2031F
  • Figure 219. South Africa Next-Generation Sequencing Market Share (%), By Product, 2017-2031F
  • Figure 220. South Africa Next-Generation Sequencing Market Share (%), By Sequencing Type, 2017-2031F
  • Figure 221. South Africa Next-Generation Sequencing Market Share (%), By Technology, 2017-2031F
  • Figure 222. South Africa Next-Generation Sequencing Market Share (%), By Application, 2017-2031F
  • Figure 223. South Africa Next-Generation Sequencing Market Share (%), By End-user, 2017-2031F
  • Figure 224. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Sequencing Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX10972

Global next-generation sequencing market is projected to witness a CAGR of 17.52% during the forecast period 2024-2031, growing from USD 10.59 billion in 2023 to USD 38.52 billion in 2031. Various elements have propelled the growth and expansion of the global next-generation sequencing market. Key factors encompass the reduction in costs, increased applications in clinical diagnostics, advancements in technology, expanding research activities, collaborative partnerships, broader uses in agriculture and animal genomics, rising demand for personalized medicine, supportive government initiatives and funding, and the escalating awareness and acceptance of NGS technologies.

In line with this, the continual decrease in sequencing expenses has notably broadened accessibility, allowing researchers and clinicians to utilize NGS across various disciplines. Simultaneously, the upsurge in NGS applications in clinical diagnostics has been transformative, harnessing its capabilities for disease identification, treatment planning, and the realm of personalized medicine, consequently enhancing its importance in healthcare. The cornerstone of advancements in sequencing technologies has consistently improved precision, speed, and cost-effectiveness, thereby increasing NGS's appeal across diverse industries and propelling the growth of global next-generation sequencing market. This momentum has been further driven by the proliferation of academic, pharmaceutical, and biotechnological research undertakings, enabling a more profound exploration of genomics and its practical applications.

Synergistic collaborations and partnerships within the global next-generation sequencing market have spurred innovation, propelling product enhancements and broadening the spectrum of NGS applications. Furthermore, the integration of NGS in agricultural and animal genomics has revolutionized practices related to crop enhancement, breeding programs, and disease analysis, extending its utility beyond human healthcare. The escalating demand for personalized medicine has emerged as a pivotal driver, harnessing NGS's capability to decipher individual genetic variations for tailor-made treatments. Supportive government initiatives and funding have incentivized research, advancement, and the widespread adoption of NGS technologies. Ultimately, the growing awareness and acceptance of NGS within the scientific community and among the general population have bolstered its significance, solidifying its pivotal role as an indispensable instrument for innovation and progress across the global next-generation sequencing market.

Increased Applications in Clinical Diagnostics

The significant increase in clinical diagnostics applications serves as a fundamental driver advancing the global next-generation sequencing market. This surge originates from NGS's transformative capabilities in identifying diseases, predicting their progression, and tailoring treatment plans. Through comprehensive genomic profiling, NGS aids in detecting disease-related genetic variations, improving diagnostic accuracy and refining treatment decisions. Its versatility spans across oncology, inherited conditions, infectious diseases, and pharmacogenomics, offering in-depth insights into individual genetic profiles. Furthermore, the ongoing enhancement of NGS technologies has diminished expenses and enhanced effectiveness, rendering it more feasible for regular clinical utilization. Consequently, the incorporation of NGS into clinical routines is expanding, catalysing a shift towards precision medicine. This amplified adoption in clinical environments not only elevates patient care standards but also propels the upward trajectory of the global NGS market, emphasizing its substantial impact on contemporary healthcare practices.

Technological Advancements

Technological advancements, notably Artificial Intelligence (AI), are potent catalysts propelling the global next-generation sequencing market forward. AI integration augments NGS by streamlining data analysis, enhancing accuracy, and expediting insights from complex genomic information. Machine learning algorithms assist in interpreting vast sequencing datasets, facilitating the identification of genetic patterns linked to diseases or therapeutic responses. This convergence of AI with NGS amplifies efficiency, reduces costs, and enables innovative applications, extending the technology's appeal across research, clinical diagnostics, and personalized medicine. Such advancements are pivotal in shaping the landscape of genomics and its widespread utilization, underscoring AI's crucial role in advancing the NGS domain.

For instance, in July 2023, South Korea's NGeneBio Co., a medical diagnostics firm, revealed the creation of "NGeneBioAI," an AI-driven precision diagnostic company in the United States. Fully financed by its parent company, NGeneBio, this venture is poised to significantly impact the US cancer diagnostics market. Leveraging its next-generation sequencing (NGS) precision diagnostic platform, NGeneBioAI aims to establish a pivotal presence in the realm of cancer diagnostics within the United States.

Government Initiatives

Governments across the globe are employing varied approaches, notably promoting collaborations between the public and private sectors, to strengthen the global next-generation sequencing market. These strategies aim to merge governmental resources with the expertise of private entities, fostering cooperation in technological advancements, genomics research, and innovative practices. Through these partnerships, governments facilitate knowledge exchange, funding accessibility and the establishment of supportive structures, hastening the uptake and advancement of NGS technologies. These coordinated endeavors leverage the strengths of both sectors, driving the expansion of the NGS market and securing its pivotal role in propelling worldwide scientific advancements and progress in healthcare.

For instance, in October 2023, The Department of Health and Human Services disclosed awards exceeding USD 500 million to aid companies advancing their vaccine candidates into Phase 2b clinical trials and innovating new technologies within Project NextGen. This initiative, a USD 5 billion government endeavour, aims to accelerate the development of next-gen vaccines and treatments via collaborations between public and private entities. The funding supports efforts to expedite vaccine development and the exploration of cutting-edge technologies, reflecting Project NextGen's commitment to catalysing advancements in the medical field through strategic partnerships.

Growing Demand for RNA Sequencing Tools

The surging desire for RNA sequencing tools is crucial in propelling the global next-generation sequencing market. This increased requirement stems from the pivotal function of RNA sequencing in interpreting gene expression, investigating transcriptomic patterns, and comprehending RNA-based mechanisms within health and disease contexts. RNA sequencing empowers the examination of various RNA molecules, enabling the elucidation of complex biological processes, discovery of biomarkers, and identification of therapeutic targets. As the scientific community increasingly acknowledges RNA's importance, the rising demand for RNA sequencing tools drives innovation in NGS technologies, significantly contributing to market expansion and advancing biological research and clinical applications.

As an example, in May 2023, Twist Bioscience Corporation-a business that empowers clients to thrive by providing premium synthetic DNA via its silicon platform-announced the introduction of a range of RNA sequencing instruments, comprising the Twist RNA Exome, Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) & Haemoglobin (Globin) Depletion Kit, in addition to customized target enrichment capabilities for RNA and whole transcriptome sequencing.

Growing Popularity of Next-Generation Sequencing Service

The increasing need for advanced sequencing services drives the global next-generation sequencing market. NGS transforms genomics, facilitating swift, cost-efficient DNA sequencing. Its wide-ranging applications in healthcare, agriculture, and research propel market growth. Heightened occurrences of genetic disorders, personalized medicine trends, and bioinformatics advancements boost NGS demand. Moreover, reduced sequencing expenses enhance its accessibility. Industries and research bodies increasingly embrace NGS due to its high-throughput capabilities and precise data, fostering market expansion. This surge in demand sustains the continual upward trajectory of the global next generation sequencing market, meeting the diverse needs across various fields seeking comprehensive genomic insights.

For instance, in August 2023, Quantum-Si, a company specializing in protein sequencing, introduced a groundbreaking Next-Generation Protein Sequencing Platform. This innovative Platinum platform, the first of its kind, offers a straightforward, user-friendly benchtop solution that seamlessly fits into current workflows. It aims to enable laboratories worldwide to perform benchtop proteomics experiments easily and effectively.

Future Market Scenario (2024-2031F)

The future of the global next-generation sequencing market holds immense promise, driven by technological progress like enhanced automation, precision, and cost reduction. NGS's adaptability spans diverse domains like healthcare, agriculture, and scientific research, amplifying its importance. Rising genetic-based treatments and diagnostics, alongside a surging demand for personalized medicine, heighten NGS's relevance in healthcare. Moreover, its application in agricultural genomics signals potential for improved crop productivity and sustainability.

Ongoing innovations in bioinformatics and data analysis refine NGS capabilities, uncovering deeper genetic insights. Advancements toward point-of-care sequencing and potential integration with AI foreshadow a future of more accessible and efficient genomic analysis. Despite challenges like data management and ethical concerns, persistent research, partnerships, and regulatory backing maintain an optimistic market trajectory. Consequently, the global NGS market appears poised for sustained growth and transformative advancements, reflecting a bright and promising future.

Key Players Landscape and Outlook

Major entities in the global next-generation sequencing market actively seek partnerships to stimulate innovation and industry expansion. These alliances facilitate the exchange of resources, merging expertise and capitalizing on complementary strengths to pioneer advanced technologies and remedies. Collaborations among leading NGS firms bolster research capacities, hasten product advancement, and enhance market reach. Through combined resources, risk-sharing, and diverse viewpoints, these partnerships target intricate issues, elevate product portfolios, and establish stronger footholds in the competitive global next-generation sequencing market. Ultimately, they cultivate a more resilient and vibrant market environment, contributing to a dynamic industry ecosystem.

To help increase local access to NGS-based testing for patients with lung and breast cancer in more than 30 countries across Latin America, Africa, the Middle East, and Asia, where advanced genomic testing has previously been limited or unavailable, Pfizer and Thermo Fisher Scientific Inc. announced in May 2023 that they had entered into a collaboration agreement.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Next-Generation Sequencing Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. Value
    • 4.1.2. Volume
  • 4.2. By Product
    • 4.2.1. NGS Consumables
    • 4.2.2. Presequencing Products & Services
    • 4.2.3. Sequencing Services
    • 4.2.4. NGS Platforms
    • 4.2.5. Bioinformatics
    • 4.2.6. Services for NGS Platforms
  • 4.3. By Sequencing Type
    • 4.3.1. RNA Sequencing
    • 4.3.2. Whole Genome Sequencing
    • 4.3.3. Whole Exome Sequencing
    • 4.3.4. Targeted Resequencing
    • 4.3.5. CHIP Sequencing
    • 4.3.6. De Novo Sequencing
    • 4.3.7. Methyl Sequencing
    • 4.3.8. Others
  • 4.4. By Technology
    • 4.4.1. Sequencing by Synthesis
    • 4.4.2. Single-Molecule Real-Time Sequencing
    • 4.4.3. Nanopore Sequencing
    • 4.4.4. Ion Semiconductor Sequencing
    • 4.4.5. Others
  • 4.5. By Application
    • 4.5.1. Drug Discovery and Personalized Medicine
    • 4.5.2. Diagnostics
    • 4.5.3. Genetic Screening
    • 4.5.4. Agriculture and Animal Research
    • 4.5.5. Others
  • 4.6. By End-user
    • 4.6.1. Hospitals & Clinics
    • 4.6.2. Academic Institutes & Research Centers
    • 4.6.3. Pharmaceutical & Biotechnology Companies
    • 4.6.4. Others
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. South America
    • 4.7.4. Asia-Pacific
    • 4.7.5. Middle East and Africa
  • 4.8. By Company Market Share (%), 2023

5. Global Next-Generation Sequencing Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. Value
      • 5.1.1.2. Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. NGS Consumables
      • 5.1.2.2. Presequencing Products & Services
      • 5.1.2.3. Sequencing Services
      • 5.1.2.4. NGS Platforms
      • 5.1.2.5. Bioinformatics
      • 5.1.2.6. Services for NGS Platforms
    • 5.1.3. By Sequencing Type
      • 5.1.3.1. RNA Sequencing
      • 5.1.3.2. Whole Genome Sequencing
      • 5.1.3.3. Whole Exome Sequencing
      • 5.1.3.4. Targeted Resequencing
      • 5.1.3.5. CHIP Sequencing
      • 5.1.3.6. De Novo Sequencing
      • 5.1.3.7. Methyl Sequencing
      • 5.1.3.8. Others
    • 5.1.4. By Technology
      • 5.1.4.1. Sequencing by Synthesis
      • 5.1.4.2. Single-Molecule Real-Time Sequencing
      • 5.1.4.3. Nanopore Sequencing
      • 5.1.4.4. Ion Semiconductor Sequencing
      • 5.1.4.5. Others
    • 5.1.5. By Application
      • 5.1.5.1. Drug Discovery and Personalized Medicine
      • 5.1.5.2. Diagnostics
      • 5.1.5.3. Genetic Screening
      • 5.1.5.4. Agriculture and Animal Research
      • 5.1.5.5. Others
    • 5.1.6. By End-user
      • 5.1.6.1. Hospitals & Clinics
      • 5.1.6.2. Academic Institutes & Research Centers
      • 5.1.6.3. Pharmaceutical & Biotechnology Companies
      • 5.1.6.4. Others
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
      • 5.1.7.1.1. Value
      • 5.1.7.1.2. Volume
      • 5.1.7.2. By Product Type
      • 5.1.7.2.1. NGS Consumables
      • 5.1.7.2.2. Presequencing Products & Services
      • 5.1.7.2.3. Sequencing Services
      • 5.1.7.2.4. NGS Platforms
      • 5.1.7.2.5. Bioinformatics
      • 5.1.7.2.6. Services for NGS Platforms
      • 5.1.7.3. By Sequencing Type
      • 5.1.7.3.1. RNA Sequencing
      • 5.1.7.3.2. Whole Genome Sequencing
      • 5.1.7.3.3. Whole Exome Sequencing
      • 5.1.7.3.4. Targeted Resequencing
      • 5.1.7.3.5. CHIP Sequencing
      • 5.1.7.3.6. De Novo Sequencing
      • 5.1.7.3.7. Methyl Sequencing
      • 5.1.7.3.8. Others
      • 5.1.7.4. By Technology
      • 5.1.7.4.1. Sequencing by Synthesis
      • 5.1.7.4.2. Single-Molecule Real-Time Sequencing
      • 5.1.7.4.3. Nanopore Sequencing
      • 5.1.7.4.4. Ion Semiconductor Sequencing
      • 5.1.7.4.5. Others
      • 5.1.7.5. By Application
      • 5.1.7.5.1. Drug Discovery and Personalized Medicine
      • 5.1.7.5.2. Diagnostics
      • 5.1.7.5.3. Genetic Screening
      • 5.1.7.5.4. Agriculture and Animal Research
      • 5.1.7.5.5. Others
      • 5.1.7.6. By End-user
      • 5.1.7.6.1. Hospitals & Clinics
      • 5.1.7.6.2. Academic Institutes & Research Centers
      • 5.1.7.6.3. Pharmaceutical & Biotechnology Companies
      • 5.1.7.6.4. Others
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Sequencing
  • 6.3. By Technology
  • 6.4. By Application
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Illumina Inc.
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Thermo Fisher Scientific Inc.
  • 13.3. BGI Group
  • 13.4. Agilent Technologies, Inc.
  • 13.5. Qiagen N.V.
  • 13.6. Macrogen, Inc.
  • 13.7. Pacific Biosciences of California, Inc.
  • 13.8. Genewiz, LLC
  • 13.9. 10x Genomics, Inc.
  • 13.10. Oxford Nanopore Technologies plc
  • 13.11. F. Hoffmann-La Roche AG

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer